Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 40,676 | 32,018 | 41,788 | 26,637 | 20,628 |
| Operating Income | -40,676 | -32,018 | -41,788 | -26,637 | -20,628 |
| Other Income | 4,386 | 4,682 | 5,014 | 5,866 | 3,147 |
| Pre-tax Income | -36,290 | -27,336 | -36,774 | -20,771 | -17,481 |
| Income Tax | 40 | 52 | 72 | 186 | N/A |
| Net Income Continuous | -36,330 | -27,388 | -36,846 | -20,957 | -17,481 |
| Net Income | $-36,330 | $-27,388 | $-36,846 | $-20,957 | $-17,481 |
| EPS Basic Total Ops | -0.67 | -0.50 | -0.68 | 35.50 | -1.60 |
| EPS Basic Continuous Ops | -0.67 | -0.50 | -0.68 | 35.52 | -1.60 |
| EPS Diluted Total Ops | -0.67 | -0.50 | -0.68 | 35.50 | -1.60 |
| EPS Diluted Continuous Ops | -0.67 | -0.50 | -0.68 | 35.52 | -1.60 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -0.50 | -0.68 | -0.39 | -1.60 |
| EBITDA(a) | $-40,620 | $-31,999 | $-41,769 | $-26,622 | $-20,613 |